Atrium Therapeutics, Inc.

Atrium Therapeutics, Inc. financial statements

Atrium Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 18.62MEODHD
Net income−USD 76.68MEODHD
Cash and equivalentsUSD 270MEODHD
Total debtUSD 3.67MEODHD

Atrium Therapeutics, Inc. financials on 6ix · Atrium Therapeutics, Inc. on 6ix